Haleon (XTER:H6D0) Short-Term Debt : €0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Short-Term Debt?

Haleon's Short-Term Debt for the quarter that ended in Mar. 2024 was €0 Mil.

Haleon's quarterly Short-Term Debt increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€706 Mil) but then declined from Dec. 2023 (€706 Mil) to Mar. 2024 (€0 Mil).

Haleon's annual Short-Term Debt declined from Dec. 2021 (€1,029 Mil) to Dec. 2022 (€452 Mil) but then increased from Dec. 2022 (€452 Mil) to Dec. 2023 (€706 Mil).

Haleon Short-Term Debt Historical Data

The historical data trend for Haleon's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Short-Term Debt Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

567.37

384.48

1,028.58

451.88

705.74

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial									-	1,230.67	-	705.74	-

Haleon Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Haleon Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Haleon's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (XTER:H6D0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (XTER:H6D0) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK HLN:UK

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon (XTER:H6D0) Headlines

No Headlines